Drugs / Roflumilust
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05369039 | Jun 2022 → Mar 2023 | chronic rhinosinusitis | Menoufia University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Roflumilust | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05369039 ↗ |
| Action | Inhibit | “A selective phosphodiesterase 4 Inhibitor” NCT05369039 ↗ |